Emerging Antimicrobial-Resistant High-Risk Klebsiella pneumoniae Clones ST307 and ST147

There is an enormous global public health burden due to antimicrobial-resistant (AMR) Klebsiella pneumoniae high-risk clones. K. pneumoniae ST307 and ST147 are recent additions to the family of successful clones in the species. Both clones likely emerged in Europe during the early to mid-1990s and,...

Full description

Bibliographic Details
Published in:Antimicrobial Agents and Chemotherapy
Main Authors: Peirano, Gisele, Chen, Liang, Kreiswirth, Barry N., Pitout, Johann D. D.
Other Authors: HHS | National Institutes of Health, Canadian Institutes of Health Research
Format: Article in Journal/Newspaper
Language:English
Published: American Society for Microbiology 2020
Subjects:
Online Access:http://dx.doi.org/10.1128/aac.01148-20
https://journals.asm.org/doi/pdf/10.1128/AAC.01148-20
Description
Summary:There is an enormous global public health burden due to antimicrobial-resistant (AMR) Klebsiella pneumoniae high-risk clones. K. pneumoniae ST307 and ST147 are recent additions to the family of successful clones in the species. Both clones likely emerged in Europe during the early to mid-1990s and, in a relatively short time, became prominent global pathogens, spreading to all continents (with the exception of Antarctica). ST307 and ST147 consist of multiple clades/clusters and are associated with various carbapenemases (i.